/
CV Risk Management in T2DM: What Did We Learn From  EASD 2016? CV Risk Management in T2DM: What Did We Learn From  EASD 2016?

CV Risk Management in T2DM: What Did We Learn From EASD 2016? - PowerPoint Presentation

marina-yarberry
marina-yarberry . @marina-yarberry
Follow
348 views
Uploaded On 2018-11-08

CV Risk Management in T2DM: What Did We Learn From EASD 2016? - PPT Presentation

Program Overview EMPAREG OUTCOME Trial Design EMPAREG OUTCOME Primary Endpoint 3Point MACE EMPAREG OUTCOME CV Death EMPAREG OUTCOME CV Death Nonfatal MI and Nonfatal Stroke EMPAREG OUTCOME ID: 722614

empa outcome sustain reg outcome empa reg sustain death leader effect cont outcomes empagliflozin trial primary design possibilities risk

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "CV Risk Management in T2DM: What Did We ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript